CHILDREN'S HEALTHCARE OF ATLANTA
CHILDREN'S HEALTHCARE OF ATLANTA filed a Q3 report for CHILDREN'S HEALTHCARE OF ATLANTA on October 20, 2026.
Lobbying for CHILDREN'S HEALTHCARE OF ATLANTA
Section 340B Drug Pricing Program Sickle cell disease research funding generally Drug pricing reforms generally Mental and behavioral health legislation generally Federal telehealth policy generally CHGME Reauthorization
Autism research programs and autism intervention programs generally, including Medicaid coverage of detection methodologies. Department of Health and Human Services programs regarding autism and sickle cell disease research H.R. 9260 (Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2027) Title II, regarding Children's Hospitals Graduate Medical Education (CHGME) program, National Institutes of Health funding, sickle cell disease research, and other programs related to pediatric healthcare. Implementation of H.R.1, Sections 71115, 71116, regarding Medicaid funding.